Accumulating evidence suggests smoking may adversely affect cancer patients’ outcomes.
Previous studies of smoking and survival in colon cancer have been limited by size and/or lack of a population basis and results have been inconsistent.
Professor Sharp and colleagues from the United Kingdom investigated in a large population-based cohort whether smoking status at diagnosis is an independent prognostic factor for cancer-specific survival in colon cancer, and whether treatment modifies any impact of smoking.
Colon adenocarcinomas diagnosed between 1994 and 2012 were abstracted from the National Cancer Registry Ireland, and classified by smoking status at diagnosis.
Cancer-specific death rates over 5 years were compared in current, ex- and never smokers using multivariable Cox proportional hazards models, and subgroup analyses by treatment were conducted.
|20% of patients were current smokers|
|Alimentary Pharmacology & Therapeutics |
Of 18,166 colon cancers, the team found that 20% of patients were current smokers, 23% ex-smokers, and 57% never smokers.
Compared to never smokers, the research team found that current smokers had a significantly raised cancer death rate.
The researchers observed a significant interaction between treatment and smoking.
In those who had cancer-directed surgery only, but not other groups, the team noted that current smokers had a significantly increased cancer death rate compared to never smokers.
Professor Sharp's team comments, "Smoking at diagnosis is an independent prognostic factor for colon cancer."
"The limitation of the association to surgically-treated patients suggests that the underlying mechanism may be related to surgery."
"While further research is needed to elucidate mechanisms, continued efforts to encourage smoking prevention and cessation may yield benefits in terms of improved survival from colon cancer."